We are live on ! Find out more
TARS icon

Tarsus Pharmaceuticals
TARS

194 hedge funds and large institutions have $2.26B invested in Tarsus Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $1.39M | Put options by funds: $627K

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

1% more capital invested

Capital invested by funds: $2.23B → $2.26B (+$29.2M)

0.33% more ownership

Funds ownership: 105.31% → 105.65% (+0.33%)

1% less funds holding

Funds holding: 195 → 194 (-1)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

22% less funds holding in top 10

Funds holding in top 10: 9 → 7 (-2)

Holders
194
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
2.6%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.09%
New
35
Increased
67
Reduced
72
Closed
34
Calls
$1.39M
Puts
$627K
Net Calls
+$764K
Net Calls Change
+$13.7M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$73.4M
2
Citadel Advisors
Citadel Advisors
Florida
+$45.1M
3
DCM
Driehaus Capital Management
Illinois
+$35.5M
4
O
OrbiMed
New York
+$32.3M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$25.2M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$19.6M
2
BlackRock
BlackRock
New York
-$19M
3
JFG
Jefferies Financial Group
New York
-$16.9M
4
ACM
AIGH Capital Management
Maryland
-$12.4M
5
PA
Perceptive Advisors
New York
-$10.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$22M +$4.51M +91,288 +27%
GGHC
27
Gilder Gagnon Howe & Co
New York
$21.4M +$622K +12,574 +3%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$21.1M +$2.23M +45,132 +12%
CAM
29
Cormorant Asset Management
Massachusetts
$20.5M -$4.94M -100,000 -20%
Norges Bank
30
Norges Bank
Norway
$20.1M +$19.3M +391,061 New
Northern Trust
31
Northern Trust
Illinois
$18.7M +$287K +5,816 +2%
RSCM
32
Rock Springs Capital Management
Maryland
$18.2M +$12M +243,487 +220%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$15.8M -$1.63M -33,075 -10%
Goldman Sachs
34
Goldman Sachs
New York
$15.5M -$851K -17,220 -5%
Charles Schwab
35
Charles Schwab
California
$14.9M -$167K -3,382 -1%
N
36
Nuveen
North Carolina
$13.6M +$6.87M +138,984 +111%
Millennium Management
37
Millennium Management
New York
$12.7M -$19.6M -396,815 -62%
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
$12.7M +$7.36M +148,848 +152%
CCM
39
Cutter Capital Management
New York
$10.5M +$4.57M +92,500 +82%
IHAM
40
Integral Health Asset Management
New York
$10.3M -$7.41M -150,000 -43%
TAM
41
TFG Asset Management
Cayman Islands
$9.17M -$1.06M -21,530 -11%
SCV
42
Sands Capital Ventures
Virginia
$8.73M – – –
Allspring Global Investments
43
Allspring Global Investments
North Carolina
$8.67M -$613K -12,401 -7%
Deutsche Bank
44
Deutsche Bank
Germany
$7.78M -$99.9K -2,020 -1%
ACM
45
Atika Capital Management
New York
$7.42M -$1.62M -32,800 -19%
JGC
46
J. Goldman & Co
New York
$7.21M +$499K +10,093 +8%
Russell Investments Group
47
Russell Investments Group
United Kingdom
$6.92M +$6.55M +132,450 +6,112%
MOACM
48
Mutual of America Capital Management
New York
$6.69M +$9.49K +192 +0.1%
ABG
49
Ally Bridge Group
New York
$6.57M -$2.23M -45,212 -26%
BFM
50
Boothbay Fund Management
New York
$6.23M -$1.74M -35,130 -22%
1
2
3 4 5

TARS Hedge Fund Activity: Q1 2025 in Review

194 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Tarsus Pharmaceuticals (TARS) for Q1 2025, worth a combined $2.26B — up 1.3% from $2.23B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new TARS positions and 34 closed out — a net gain of 1 holder — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $73.4M. The largest seller was Millennium Management, cutting an estimated $19.6M.

  • 194 institutional investors held Tarsus Pharmaceuticals (TARS) as of Q1 2025, down from 195 in Q4 2024.
  • Funds reported $2.26B of Tarsus Pharmaceuticals stock for Q1 2025, up 1.3% quarter-over-quarter.
  • 35 funds opened new Tarsus Pharmaceuticals positions in Q1 2025 and 34 closed out, a net change of +1 holder.
  • The largest Tarsus Pharmaceuticals buyer in Q1 2025 was Deep Track Capital, an estimated $73.4M added.
  • The largest Tarsus Pharmaceuticals seller in Q1 2025 was Millennium Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q1 2025.